---
title: "Novo Nordisk lowers outlook, triggering a historic 20% plunge; shareholders initiate class action lawsuit"
description: "Novo Nordisk is facing a shareholder lawsuit due to a downward revision of its full-year revenue and operating profit growth expectations, citing resistance in the GLP-1 market as the reason for the d"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/251554990.md"
published_at: "2025-08-05T03:43:03.000Z"
---

# Novo Nordisk lowers outlook, triggering a historic 20% plunge; shareholders initiate class action lawsuit

> Novo Nordisk is facing a shareholder lawsuit due to a downward revision of its full-year revenue and operating profit growth expectations, citing resistance in the GLP-1 market as the reason for the downgrade. The company's American Depositary Receipts (ADR) plummeted over 20% last Tuesday, marking the most severe intraday drop for the stock since 1987. On July 28 (Friday), a group of Novo Nordisk (NVO) shareholders filed a proposed class action lawsuit against the Danish company in federal court in New Jersey, seeking to recover losses allegedly caused by securities fraud from May 7 to July 28, 2025. The plaintiffs allege that Novo Nordisk made overly optimistic statements during this period and disseminated false and misleading statements that exaggerated its growth potential while concealing significant adverse facts, ultimately leading to a stock price crash due to the lowered performance guidance, resulting in losses for shareholders

According to the Zhitong Finance APP, Novo Nordisk (NVO.US) is facing a shareholder lawsuit due to a downward revision of its full-year revenue and operating profit growth expectations, citing resistance in the GLP-1 market as the reason for the downgrade.

The American Depositary Receipts (ADR) of this weight loss drug manufacturer plummeted over 20% last Tuesday, marking the most severe intraday drop for the stock since 1987.

On July 28 (Friday), a group of Novo Nordisk (NVO) shareholders filed a proposed class action lawsuit against the Danish company in federal court in New Jersey, seeking to recover losses allegedly caused by securities fraud from May 7 to July 28, 2025.

The plaintiffs allege that Novo Nordisk made overly optimistic statements during this period and disseminated false and misleading statements, exaggerating its growth potential while concealing significant adverse facts, ultimately leading to a stock price crash due to the lowered performance guidance, resulting in shareholder losses

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk (0QIU) Receives a Buy from Kepler Capital | Kepler Capital analyst David Evans has maintained a Buy rating on Novo Nordisk, setting a price target of DKK400.00. The | [Link](https://longbridge.com/en/news/276501273.md) |
| As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | [Link](https://longbridge.com/en/news/270794581.md) |
| Brazil's Copasa says bookrunners tapped for potential privatization share offering | Companhia de Saneamento de Minas Gerais Copasa MG :BTG PACTUAL, ITAU BBA, BOFA, CITI AND UBS BB TAPPED AS BOOKRUNNERS OF | [Link](https://longbridge.com/en/news/276494934.md) |
| Top Eversource Energy Insiders Quietly Cash Out in Major Stock Moves | Eversource Energy (ES) experienced significant insider selling on February 20, 2026, with Trustee John Y Kim selling 6,0 | [Link](https://longbridge.com/en/news/276501481.md) |
| Top Westinghouse Executive Makes Notable Move With Company Stock | Westinghouse Air Brake Technologies (WAB) EVP Gregory Sbrocco sold 952 shares valued at $246,025 on February 20, 2026. F | [Link](https://longbridge.com/en/news/276501280.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.